ImmuCell Corporation ICCC

9.93 (0.04) (0.40%) as of 25 Sep
Market cap
$90.6M
P/E
117×
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
43.18 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
2.63 3.92 3.52 2.56 2.80 3.16 2.70 2.22 1.59 2.01
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 44.02
P/Operating CF
(67.59) 123.76 (279.67) (753.60) 274.58 103.31 (38.67) (53.58) (13,568.09) 115.05
P/B ratio
1.28 1.73 1.78 1.21 1.52 1.86 1.65 1.55 1.53 2.05
Price to Tangible BV
1.29 1.75 1.80 1.22 1.53 1.87 1.66 1.56 1.53 2.06
EV/Sales
1.84 4.42 4.18 2.53 2.90 3.10 2.94 2.85 1.84 2.20
EV/EBITDA
10.36 69.66 504.64 26.13 41.57 21.89 278.42 0.00 44.82 13.72
EV/Operating CF
(78.87) 39.19 (122.98) 148.89 33.80 62.55 (35.38) (10.64) 136.47 24.56
EV/FCF
(4.64) (2.79) (21.33) (49.11) (16.40) (36.41) (9.92) (7.58) (472.81) 48.22
Quick Ratio
5.64 2.49 1.35 4.17 4.41 5.08 2.46 0.75 1.71 1.82
Current Ratio
6.97 3.64 2.50 5.29 5.50 6.42 4.56 2.73 3.41 4.26
Net Debt/EBITDA
(4.50) 7.79 79.61 (0.26) 1.45 (0.38) 22.61 (3.65) 6.22 1.19
Debt/Assets
12.20% 26.11% 29.84% 21.77% 23.54% 20.55% 22.81% 27.32% 23.37% 21.39%
Debt/Equity
0.15 0.38 0.45 0.29 0.34 0.28 0.34 0.48 0.38 0.34
Asset Turnover
0.49 0.35 0.33 0.38 0.39 0.45 0.42 0.39 0.60 0.63
Operating CF/Net income
(0.44) (6.99) 0.16 (0.18) (1.29) (12.19) 0.62 0.81 (0.17) (2.38)
Capex/Depreciation
(4.43) (19.59) (1.16) (0.41) (1.64) (1.05) (1.59) (0.69) (0.17) (0.44)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
3.35% (0.78%) (10.24%) (5.11%) (3.57%) (0.26%) (7.92%) (20.86%) (8.21%) (3.81%)
ROA
2.59% (0.57%) (6.93%) (3.63%) (2.59%) (0.18%) (5.58%) (13.03%) (4.85%) (2.37%)
ROIC
4.59% (0.53%) (3.12%) (2.08%) (2.89%) 0.51% (4.13%) (9.98%) (2.99%) 3.19%
Return on Tangible Assets
2.30% (0.53%) (7.77%) (3.60%) (2.78%) (0.19%) (6.34%) (16.57%) (5.99%) (3.06%)
Average Days of Receivables
37.95 47.03 30.97 43.55 42.75 51.10 34.57 45.66 51.95 45.14
Research and Development Expense of Revenue
13.04% 19.62% 32.01% 26.87% 28.38% 21.66% 24.20% 25.15% 14.72% 11.00%
Selling, General and Administrative Expense of Revenue
34.43% 32.76% 34.81% 29.19% 25.35% 21.98% 29.37% 29.89% 21.45% 24.43%
Intangible Assets out of Total Assets
0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.71% 1.92% 3.13% 2.28% 1.65% 0.75% 1.43% 2.11% 1.23% 1.07%
Graham Net Nets
0.37 (0.08) (0.12) 0.10 0.00 0.07 (0.01) (0.19) (0.06) 0.03
Graham Number
3.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
2.32% (0.48%) (6.10%) (3.69%) (2.35%) (0.13%) (5.00%) (15.00%) (5.63%) (1.71%)
Free Cash Flow Yield
(15.02%) (40.41%) (5.57%) (2.02%) (6.32%) (2.70%) (10.98%) (16.94%) (0.25%) 2.27%
Revenue per Share
2.26 2.11 2.00 2.01 2.13 2.53 2.40 2.26 3.24 3.06
Operating CF per Share
(0.05) 0.24 (0.07) 0.03 0.18 0.13 (0.20) (0.60) 0.04 0.27
Capex per Share
(0.84) (3.58) (0.32) (0.14) (0.56) (0.34) (0.51) (0.24) (0.06) (0.13)
Free Cash Flow per Share
(0.89) (3.34) (0.39) (0.10) (0.38) (0.22) (0.71) (0.85) (0.01) 0.14
Cash per Share
2.51 0.77 0.46 1.29 1.10 1.34 0.75 0.13 0.46 0.42
Shareholders Equity per Share
4.67 4.77 3.96 4.25 3.92 4.29 3.92 3.23 3.37 3.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
4.67 4.77 3.96 4.25 3.92 4.29 3.92 3.23 3.37 3.00
Free Cash Flow
(3.78) (16.54) (2.15) (0.71) (2.71) (1.64) (5.51) (6.56) (0.10) 1.26
Working Capital
12.29 5.44 3.86 10.69 9.95 13.73 10.92 7.27 10.63 12.97
Capital Expenditures
(3.56) (17.71) (1.78) (0.94) (4.03) (2.59) (3.96) (1.89) (0.46) (1.21)
Net Current Asset Value
9.37 (3.20) (4.57) 3.49 0.07 4.38 (0.49) (7.35) (2.54) 1.47
EV/EBIT
19.69 0.00 0.00 0.00 0.00 231.90 0.00 0.00 0.00 36.87
Capex to Sales
0.37 1.70 0.16 0.07 0.26 0.13 0.21 0.11 0.02 0.04
Net Profit Margin
5.33% (1.61%) (21.13%) (9.44%) (6.66%) (0.41%) (13.43%) (33.05%) (8.14%) (3.76%)
Price to Operating Income
28.24 0.00 0.00 0.00 0.00 235.96 0.00 0.00 0.00 33.66
Other line items
Depreciation/Fixed assets
0.08 0.03 0.06 0.09 0.09 0.09 0.09 0.10 0.11 0.13
Cash ROIC
(30.18%) (68.49%) (77.58%) (54.20%) (55.65%) (49.98%) (64.62%) (85.00%) (59.77%) (46.54%)
Accounts Receivable Turnover
11.16 8.93 9.65 10.68 8.94 8.57 8.34 8.86 8.90 7.69
Accounts Payable Turnover
3.23 2.88 3.94 5.72 6.60 7.14 6.04 6.59 8.05 6.80
Inventory Turnover
2.75 2.49 2.64 2.88 3.68 4.09 2.39 1.96 2.49 1.98
Average Days of Payables
167.46 120.74 76.92 63.80 58.12 55.66 66.88 57.00 48.84 51.43
Days of Inventory on Hand
188.28 143.61 146.93 131.63 90.07 106.53 201.85 209.62 139.94 208.82
Average Receivables
0.86 1.17 1.14 1.28 1.72 2.25 2.23 1.97 2.98 3.60
Average Payables
1.28 1.81 1.47 1.22 1.29 1.48 1.81 2.06 2.30 2.38
Average Inventory
1.50 2.09 2.19 2.43 2.31 2.59 4.56 6.93 7.46 8.19
Average Assets
19.62 29.50 33.51 35.71 39.52 42.41 44.66 44.33 44.45 43.82
Average Common Equity
15.17 21.66 22.67 25.37 28.63 30.42 31.48 27.69 26.26 27.29

Fold the line items

Columns are period end dates